| Wissenschaftl. Titel | An Open Label, Randomized Phase 2 Clinical Trial of Nivolumab investigating Effiacy and safety of Nivolumab given once prior to, concurrent to the radiotherapy (RT) and as maintenance therapy over 12 months in patients with advanced resectable HNSCC after surgery (NadiHN) |
| Erkrankung |
Kopf-Hals:
Plattenepithelkarzinom:
Erstlinie
|
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (K) Weiterführende Informationen (EudraCT) |
erstellt 30.10.2018 Data entry I CCP
geändert 30.08.2021 Data entry IX CCP